Innovating.works Conecta tu I+D

Showing 1 to 20 of 41 results

UMBRELLA: Unleashing a CoMprehensive Holistic and Patient Centric Stroke Management for a Better Rapid Adva... "UMBRELLA is a holistic approach to progress, reshape, and benchmark the overall stroke care pathway and set new and improved standards of c...
2024-07-31 - 2029-09-30 | Financiado

HBP SGA3: Human Brain Project Specific Grant Agreement 3 UNIVERSITATSSPITAL BASEL participó en un H2020: The last of four multi-year work plans will take the HBP to the end of its original incarnation as an EU Future and Emerging Technology Flag...
2020-06-03 - 2023-09-30 | Financiado

Hemstem: Targeting leukaemia by modulating hematopoietic stem cell competitiveness UNIVERSITATSSPITAL BASEL participó en un H2020: ERC-2019-COG Human acute myeloid leukemia (AML) remains a devastating disease with less than 30% of patients surviving five years after diagnosis. Despit...
2020-02-25 - 2025-12-31 | Financiado

cmRNAbone: 3D Printed Matrix Assisted Chemically Modified RNAs Bone Regenerative Therapy for Trauma and Osteopo... UNIVERSITATSSPITAL BASEL participó en un H2020: H2020-SC1-BHC-2018-2020 Due to life style changes and ageing of our industrialized nations, bone traumatic injuries and osteoporosis induced fragile fracture are an...
2019-11-24 - 2024-06-30 | Financiado

3TR: Identification of the Molecular Mechanisms of non response to Treatments Relapses and Remission in... UNIVERSITATSSPITAL BASEL participó en un H2020: H2020-JTI-IMI2-2018-14-two-stage 3TR is a transdisciplinary consortium made of experts in all areas of medicine, basic sciences and bioinformatics from academic institutions...
2019-08-22 - 2026-08-31 | Financiado

TALE: Therapeutic Allele Engineering A novel technology for cell therapy UNIVERSITATSSPITAL BASEL participó en un H2020: ERC-2018-COG We are currently witnessing a revolution in cell therapies that are routed in decades of basic research in genetics, cell biology and immuno...
2019-02-07 - 2025-05-31 | Financiado

EpiCrest2Reg: From Epigenetics of Cranial Neural Crest Plasticity to Intervertebral Disc Regeneration UNIVERSITATSSPITAL BASEL participó en un H2020: ERC-2018-SyG During craniofacial development, Cranial Neural Crest Cells (CNCCs) maintain broad plasticity and patterning competence until they make appr...
2019-02-05 - 2025-02-28 | Financiado

ICEI: Interactive Computing E Infrastructure for the Human Brain Project UNIVERSITATSSPITAL BASEL participó en un H2020: Five leading European supercomputing centres are committed to develop, within their respective national programs and service portfolios, a s...
2018-07-16 - 2023-09-30 | Financiado

B2B: Modeling spontaneous Breast cancer metastasis TO the Bone with a first of its kind 3D device that re... UNIVERSITATSSPITAL BASEL participó en un H2020: H2020-FETOPEN-2016-2017 Cancer patients developing a metastatic disease are considered incurable. Breast cancer hits 1 woman in 8, and its most common metastatic si...
2018-05-25 - 2022-12-31 | Financiado

HBP SGA2: Human Brain Project Specific Grant Agreement 2 UNIVERSITATSSPITAL BASEL participó en un H2020: The Human Brain Project (HBP) is a major European scientific research initiative to improve our understanding of the brain and the role it p...
2018-05-03 - 2020-03-31 | Financiado

HBP SGA1: Human Brain Project Specific Grant Agreement 1 UNIVERSITATSSPITAL BASEL participó en un H2020: Understanding the human brain is one of the greatest scientific challenges of our time. Such an understanding can provide profound insights...
2016-08-26 - 2018-03-31 | Financiado

STEM-BCPC: Signal Transduction and Epigenetic Mechanisms of Breast Cell Plasticity and Cancer UNIVERSITATSSPITAL BASEL participó en un H2020: ERC-2015-AdG Breast cancer is diagnosed in ~1.4 million women worldwide and ~500,000 lives are lost to the disease annually. Patients may do well after s...
2016-06-22 - 2022-09-30 | Financiado

FORCE: Imaging the Force of Cancer UNIVERSITATSSPITAL BASEL participó en un H2020: H2020-PHC-2014-2015 Cancer is the second leading cause of mortality in EU member states with ~90% of all cancer deaths caused by metastatic spread. Despite its...
2015-12-09 - 2021-07-31 | Financiado

BIO-CHIP: BIOengineered grafts for Cartilage Healing In Patients BIO CHIP UNIVERSITATSSPITAL BASEL participó en un H2020: H2020-PHC-2014-2015 Spontaneous healing of articular cartilage injuries is poor and untreated defects predispose to osteoarthritis. Current therapies, including...
2015-09-30 - 2020-10-31 | Financiado

ELASTISLET: Tailored Elastin like Recombinamers as Advanced Systems for Cell Therapies in Diabetes Mellitus a S... UNIVERSITATSSPITAL BASEL participó en un H2020: H2020-NMP-2014-2015 ELASTISLET aims to create a breakthrough development in encapsulation technology and its use in cell and tissue therapies for the treatment...
2015-05-28 - 2019-05-31 | Financiado

TBVAC2020: TBVAC2020 Advancing novel and promising TB vaccine candidates from discovery to preclinical and ear... UNIVERSITATSSPITAL BASEL participó en un H2020: H2020-PHC-2014-2015 The TBVAC2020 proposal builds on the highly successful and long-standing collaborations in subsequent EC-FP5-, FP6- and FP7-funded TB vaccin...
2014-12-03 - 2019-06-30 | Financiado

ABIRISK: Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the ri... UNIVERSITATSSPITAL BASEL participó en un FP6: The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique pane...
2012-03-01 - 2018-02-28 | Financiado

TERRAINCOGNITA: T cell receptor in control of signal initiation and T cell fate UNIVERSITATSSPITAL BASEL tramitó un FP7: One of the central mysteries of immunology is self-tolerance. How does the human body select ~10e12 T lymphocytes, that are reactive to fore...
Financiado

BIO-COMET: Bioreactor based clinically oriented manufacturing of engineered tissues UNIVERSITATSSPITAL BASEL tramitó un FP7: Despite significant achievements in the field of regenerative medicine and the enormous potential for engineered tissue products, significan...
Financiado

TARCC: Targeting alpha particle emitting radionuclides to combat cancer UNIVERSITATSSPITAL BASEL participó en un FP7: This project aims at improving drug delivery to cancer cells by developing targeted radiotherapy with alpha-emitting radionuclides. Alpha pa...
Financiado

KANTONSSPITAL BASEL